Study Of A Ribonuclease And Its Inhibitor From Bacillus

芽孢杆菌核糖核酸酶及其抑制剂的研究

基本信息

项目摘要

Two proteins, barnase, the extracellular ribonuclease of Bacillus amyloliquefaciens, and barstar, its intracellular inhibitor, are used as a model system for the study of protein folding and protein-protein interactions. Barnase is one of a homologous group of ribonucleases occurring in both prokaryotes and eukaryotes. Recombinant DNA techniques are being applied with three major aims: (1) to facilitate production of wild type and mutant proteins; (2) to examine the structural and control sequences of the genes; and (3) to make specific changes in the sequences to test theories of folding and to probe the barnase-barstar interaction. Both proteins can now be obtained from recombinant genes in E. coli where expression of barstar counters the lethal effect of barnase expression. The structures of both proteins and their complex are known, barnase at 1.5 Angstrom resolution. Crystal structures of several barnase-barstar pairs having complementary mutations in the interface, obtained by an in vivo selective technique, have been solved, providing insight into the mechanisms that determine the strength of the bond. Barstar also inhibits a group of RNases from Streptomyces strains. These enzymes are distantly related to barnase with a sequence identity of only 25%. Among the four such enzymes in hand, identities range from 40% to 70%. Cloned and expressed in E.coli with the aid of barstar, several of these have been well characterized. The genes for barstar homologs from three other strains of B. amyloliquefaciens plus one, the yrdF gene from B. subtilis 168 and another, Sti from S. erythreus have been cloned and their products found to cross react with barnase. Cloning of the Sti gene required the use of phage display technology. A phage display system has been developed for selection of varieties or homologs of barstar that bind tightly to barnase or its mutants. Procedures have been developed for total synthesis of the barstar gene with randomization of selected hydrophobic core residues with a multiplicity (the number of independently randomized sequences) on the order of 10exp9. From a library for which a compact clump of eight core residues were randomized ( to L, I, V, M or F) 30 clones producing functional barstars were obtained, 21 of which provided yields comparable to the wild type. At only one position in this group, at F74, was the wild type residue required. From a larger library with all 22 of the core residues similarly randomized, we have found fewer functional barstars but in this larger context no wild type residues are irreplaceable. Is the limited number of basic protein folds found in nature an historical accident of evolution or is it due to some fundamental geometric limitation? We are currently trying to answer this question by using ribosome display to search for a well folded protein produced by a synthetic gene library designed to yield a novel tertiary structure made up of elements of secondary structure taken from barnase and barstar but with a randomized hydrophobic core.
以淀粉解冻芽孢杆菌胞外核糖核酸酶barnase和胞内核糖核酸酶抑制物barstar两种蛋白质作为蛋白质折叠和蛋白质相互作用研究的模型体系。Barnase是存在于原核生物和真核生物中的一组同源核糖核酸酶之一。重组DNA技术的应用有三个主要目的:(1)促进野生型和突变型蛋白质的生产;(2)检查基因的结构和控制序列;(3)对序列进行特定的改变,以检验折叠理论和探索Barnase-barstar相互作用。这两种蛋白质现在都可以从大肠杆菌中的重组基因中获得,其中barstar的表达抵消了barnase的表达的致死作用。这两种蛋白质及其复合体的结构都是已知的,Barnase的分辨率为1.5埃。通过体内选择技术获得的几个在界面上具有互补突变的barnase-barstar对的晶体结构已经被解决,这为决定键强度的机制提供了洞察。Barstar还抑制链霉菌菌株的一组核糖核酸酶。这些酶与Barnase有较远的亲缘关系,序列同源性仅为25%。在手头的四种这样的酶中,同一性从40%到70%不等。在Barstar的帮助下,克隆并在大肠杆菌中表达,其中几个已经得到了很好的鉴定。另外三个菌株的barstar同源物基因已被克隆,其中一个是枯草芽孢杆菌168的yrdF基因,另一个是红苏链霉菌的Sti,它们的产物与Barnase发生交叉反应。STI基因的克隆需要使用噬菌体展示技术。已建立了一种噬菌体展示系统,用于筛选与barnase或其突变体紧密结合的barstar的变种或同源物。已经开发了通过选择的具有10exp9量级的重复性(独立随机序列的数目)的所选疏水核心残基的随机化来全合成barstar基因的程序。从一个由8个核心残基组成的紧凑型文库中(随机分为L、I、V、M或F),获得了30个产生功能性Barstar的无性系,其中21个的产量与野生型相当。在这个组中只有一个位置,即F74,是所需的野生型残留物。从一个更大的文库中,所有22个核心残基都是类似随机的,我们发现功能棒星较少,但在这个更大的背景下,没有野生型残基是不可替代的。 自然界中发现的有限数量的碱性蛋白质折叠是进化的历史偶然,还是由于一些基本的几何限制?我们目前正试图通过使用核糖体展示来搜索由合成基因库产生的折叠良好的蛋白质,该基因库旨在产生一种新的三级结构,该三级结构由来自barnase和barstar的二级结构元素组成,但具有随机的疏水核心。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
[Modified ribonuclease gene provides efficient positive selection in molecular cloning]
[修饰核糖核酸酶基因为分子克隆提供高效的正向选择]
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Deev,SM;Iazynin,SA;Hartley,RW
  • 通讯作者:
    Hartley,RW
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT W HARTLEY其他文献

ROBERT W HARTLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT W HARTLEY', 18)}}的其他基金

Study Of A Ribonuclease And Its Inhibitor From Bacillus
芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6673341
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Study Of A Ribonuclease And Its Inhibitor From Bacillus
芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6809835
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6289714
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Study Of A Ribonuclease And Its Inhibitor From Bacillus
芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6532081
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6432055
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6104998
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

Streptomyces rochei D21E05 次级代谢产物分离纯化及其活性功能研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Streptomyces rimosus M527特异性高强度合成龟裂霉素的多模块协同改造
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
深海放线菌Streptomyces sp. 11695的抗菌活性次级代谢产物基因组挖掘
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于TAG途径解析 Streptomyces exfoliates A1013Y中蓝色素代谢调控分子机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
基因导向的海洋链霉菌Streptomyces sp. LC13中次级代谢产物的挖掘和bacaryolane C的生物合成研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
放线菌Streptomyces mediolani EM-B2的生物脱氮机理研究
  • 批准号:
    42167019
  • 批准年份:
    2021
  • 资助金额:
    36 万元
  • 项目类别:
    地区科学基金项目
天目山来源链霉菌Streptomyces sp. SY1322中morindolestatin类新颖咔唑生物碱获取及其铁死亡抑制活性研究
  • 批准号:
    LY21H300001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
链霉菌新菌株Streptomyces samsunensis F2农用抗生素先导物发掘及生防机制研究
  • 批准号:
    2020JJ4386
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Streptomyces sp. Gö66 中基于基因组挖掘的新颖非核糖体肽的发现及生物合成机制的研究
  • 批准号:
    31972852
  • 批准年份:
    2019
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
链霉菌Streptomyces sp. G0051B 中膦酸类抗生素Argolaphos A的生物合成研究
  • 批准号:
    31870050
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目

相似海外基金

Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
NSF PRFB FY 2023: Does long-term selection for growth on recalcitrant vs labile carbon impact Streptomyces nutrient use or inhibitory phenotypes?
NSF PRFB 2023 财年:顽固性碳与不稳定碳的长期选择是否会影响链霉菌的营养利用或抑制表型?
  • 批准号:
    2305753
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fellowship Award
Using CRISPR/Cas9 genome editing to facilitate antibiotic discovery in novel Streptomyces species
使用 CRISPR/Cas9 基因组编辑促进新链霉菌物种中抗生素的发现
  • 批准号:
    BB/X00967X/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fellowship
EAGER: Plant pathogenic Streptomyces encode components for genetic code mistranslation
EAGER:植物致病性链霉菌编码遗传密码误译成分
  • 批准号:
    2304710
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Studies on mining of novel enzymes functioning in secondary metabolite biosynthesis in Streptomyces and their molecular mechanism.
链霉菌次级代谢产物生物合成新型酶的挖掘及其分子机制研究。
  • 批准号:
    22H00355
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Elucidation of molecular basis of Streptomyces signaling-molecule-dependent regulatory pathway and activation of silent secondary metabolite biosynthetic genes
阐明链霉菌信号分子依赖性调控途径的分子基础和沉默次级代谢产物生物合成基因的激活
  • 批准号:
    22H02274
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development-Associated Linear Chromosome Segregation in Streptomyces
链霉菌中发育相关的线性染色体分离
  • 批准号:
    10579038
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Elucidating the role of concanamycins in the pathogenicity of Streptomyces scabiei.
阐明刀刀霉素在疥疮链霉菌致病性中的作用。
  • 批准号:
    572338-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Secondary metabolism in plant pathogenic Streptomyces species
植物致病链霉菌的次生代谢
  • 批准号:
    RGPIN-2018-05155
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Post-translation regulation of antibiotic production in Streptomyces: the loaded gun hypothesis.
链霉菌抗生素生产的翻译后调控:装弹枪假说。
  • 批准号:
    BB/W000628/1
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了